IS7858A - Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD) - Google Patents

Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD)

Info

Publication number
IS7858A
IS7858A IS7858A IS7858A IS7858A IS 7858 A IS7858 A IS 7858A IS 7858 A IS7858 A IS 7858A IS 7858 A IS7858 A IS 7858A IS 7858 A IS7858 A IS 7858A
Authority
IS
Iceland
Prior art keywords
adhd
treatment
composition
Prior art date
Application number
IS7858A
Other languages
English (en)
Inventor
Vincent Edward Groppi, Jr.
Jon Jacobsen Eric
Kenneth Myers Jason
Walter Piotrowski David
Nelsen Rogers Bruce
Patrick Walker Daniel
Gregory Wishka Donn
Original Assignee
Pharmacia & Upjohn Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company Llc filed Critical Pharmacia & Upjohn Company Llc
Publication of IS7858A publication Critical patent/IS7858A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Liquid Crystal Substances (AREA)
IS7858A 2002-12-11 2005-05-23 Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD) IS7858A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43258602P 2002-12-11 2002-12-11
PCT/IB2003/005542 WO2004052461A1 (en) 2002-12-11 2003-11-28 Combination for the treatment of adhd

Publications (1)

Publication Number Publication Date
IS7858A true IS7858A (is) 2005-05-23

Family

ID=32507968

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7858A IS7858A (is) 2002-12-11 2005-05-23 Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD)

Country Status (23)

Country Link
US (1) US20050107425A1 (is)
EP (1) EP1572300A1 (is)
JP (1) JP2006510663A (is)
KR (1) KR20050085538A (is)
CN (1) CN1735441A (is)
AP (1) AP2005003336A0 (is)
AU (1) AU2003283656A1 (is)
BR (1) BR0317229A (is)
CA (1) CA2509142A1 (is)
CO (1) CO5700801A2 (is)
CR (1) CR7868A (is)
EA (1) EA200500783A1 (is)
EC (1) ECSP055852A (is)
HR (1) HRP20050522A2 (is)
IS (1) IS7858A (is)
MA (1) MA27606A1 (is)
MX (1) MXPA05006336A (is)
NO (1) NO20053185L (is)
OA (1) OA12969A (is)
PL (1) PL377552A1 (is)
TN (1) TNSN05158A1 (is)
WO (1) WO2004052461A1 (is)
ZA (1) ZA200504338B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
GB0310867D0 (en) * 2003-05-12 2003-06-18 Novartis Ag Organic compounds
NZ550534A (en) 2004-03-25 2009-07-31 Memory Pharm Corp Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
GB0424564D0 (en) * 2004-11-05 2004-12-08 Novartis Ag Organic compounds
WO2008083442A1 (en) * 2007-01-10 2008-07-17 Brc Operations Pty Limited Method for formulating combination medications for adhd
JP2010522766A (ja) * 2007-03-28 2010-07-08 ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー １１ベータ−ｈｓｄ１活性化合物
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
EP2285818A4 (en) * 2008-02-19 2011-08-17 Adolor Corp BELOXEPINE, ITS ENANTIOMERS AND ANALOGUE FOR PAIN TREATMENT
AU2009316802B2 (en) 2008-11-21 2015-02-26 Vtv Therapeutics Llc Adamantyl benzamide compounds
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
ES2746850T3 (es) 2010-05-17 2020-03-09 Forum Pharmaceuticals Inc Formulaciones farmacéuticas que comprenden formas cristalinas de clorhidrato de (R)-7-cloro-N-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida monohidratado
US8513430B2 (en) 2010-07-27 2013-08-20 High Point Pharmaceuticals, Llc Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
MX358512B (es) 2012-05-08 2018-08-24 Forum Pharmaceuticals Inc Uso de (r)-7cloro-n-(quinuclidin-3-il) benzo[b] tiofeno-2-carboxamida o una sal farmacéuticamente aceptable de la misma para preparar una composición farmacéutica en el tratamiento de una disfunción cognitiva.
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2023022256A1 (ko) 2021-08-19 2023-02-23 단국대학교 천안캠퍼스 산학협력단 Kds2010을 유효성분으로 포함하는 주의력결핍 과잉행동장애의 예방 또는 치료용 약학적 조성물
WO2023022269A1 (ko) 2021-08-20 2023-02-23 단국대학교 천안캠퍼스 산학협력단 주의력결핍 과잉행동장애의 예방 또는 치료용 약학적 조성물
KR102597711B1 (ko) 2021-08-20 2023-11-06 단국대학교 천안캠퍼스 산학협력단 Snap5114을 유효성분으로 포함하는 주의력결핍 과잉행동장애의 예방 또는 치료용 약학적 조성물
KR20230027862A (ko) 2021-08-20 2023-02-28 단국대학교 천안캠퍼스 산학협력단 주의력결핍 과잉행동장애의 진단을 위한 gat-3의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US20030236287A1 (en) * 2002-05-03 2003-12-25 Piotrowski David W. Positive allosteric modulators of the nicotinic acetylcholine receptor

Also Published As

Publication number Publication date
TNSN05158A1 (fr) 2007-05-14
ECSP055852A (es) 2005-09-20
NO20053185D0 (no) 2005-06-29
CA2509142A1 (en) 2004-06-24
JP2006510663A (ja) 2006-03-30
US20050107425A1 (en) 2005-05-19
AP2005003336A0 (en) 2005-06-30
KR20050085538A (ko) 2005-08-29
CO5700801A2 (es) 2006-11-30
PL377552A1 (pl) 2006-02-06
CR7868A (es) 2005-07-08
OA12969A (en) 2006-10-13
CN1735441A (zh) 2006-02-15
ZA200504338B (en) 2006-07-26
NO20053185L (no) 2005-08-17
MA27606A1 (fr) 2005-11-01
EP1572300A1 (en) 2005-09-14
AU2003283656A1 (en) 2004-06-30
BR0317229A (pt) 2005-11-01
EA200500783A1 (ru) 2005-12-29
WO2004052461A1 (en) 2004-06-24
HRP20050522A2 (en) 2005-12-31
MXPA05006336A (es) 2005-08-26

Similar Documents

Publication Publication Date Title
IS7858A (is) Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD)
IS8267A (is) [1,8]naftýridín-2-ón og tengd efnasambönd til notkunar við meðferð á geðklofa
IS7738A (is) Þíasól efnasambönd til notkunar í meðferð á taugahrörnunar truflunum.
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
IS7806A (is) Ónæmisvaldandi samsetning
DK1501815T3 (da) Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
DE60317699D1 (de) Fermentationsverfahren und -zusammensetzungen
IS7520A (is) Pyrimidínonefnasambönd, samsetningar og aðferðir
DE502004002801D1 (de) Bohrlochbehandlungsmittel, enthaltend ethercarbonsäuren
DE60315257D1 (de) Polierverfahren und polierflüssigkeit
DK3384931T3 (da) Superfin formoterolformulering
DE10393374D2 (de) Zusammensetzung
DE60305827D1 (de) Polierzusammensetzung
SE0500163L (sv) Sammansättning
DE60302398D1 (de) Poliervorrichtung
NO20042616L (no) Kjolemediumsblanding og kjolesyklusapparatur for anvendelse derav
NO20045554L (no) Fremgangsmate for behandling av diabetes
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
DE50303208D1 (de) Osteosyntheseeinrichtung
DE60216645D1 (de) Antiulcus pflanzenzusammensetzung(en)
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
NO20024880L (no) Sammensetning inneholdende fosfat
NO20044140D0 (no) New Composition
DE60311273D1 (de) Gemischtes schmuckset